Reports
Global Anaesthesia Drugs Market: By Route of Administration: Inhalation, Injection, Others; By Drug Type: General Drug, Local Drug; By Application: General Surgery, Plastic Surgery, Others; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Anaesthesia Drugs Market Outlook
The global anaesthesia drugs market stood at a value of nearly USD 5.91 billion in 2020. The market is further expected to grow at a CAGR of 3.4% in the forecast period of 2023-2028 to attain a value of almost USD 7.22 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Growing Use of Local Drugs to Augment the Global Anaesthesia Drugs Industry
On the basis of drug type, the local drug segment accounted for a significant share in the market and is anticipated to witness a steady growth over the forecast period. The growth can be attributed to the rising demand for local drugs in various applications, particularly dental surgeries. The anticipated increase in minor procedures such as filling or wisdom tooth removal is expected to bolster the demand for local anaesthetics. Meanwhile, the growing awareness about the benefits of general drugs, which include reduced intraoperative patient awareness and complete control of the airway, breathing and circulation, among others, is expected to aid the growth of the segment.
Based on the route of administration, the inhalation segment is likely to account for a significant share in the market owing to the cost-effectiveness of the method and its precise control over the anaesthetic state. Also, the inhaled anaesthetics have a low solubility in the blood and tissues, possess a protective effect and are resistant to physical and metabolic degradation, thus, further contributing to the demand growth.
North America Accounts for a Significant Share in the Global Anaesthesia Drugs Industry
North America, due to rapid technological advancements and the high healthcare expenditure, accounts for a considerable share in the market. The region is further expected to be aided by the increasing number of surgeries in countries like the United States and Canada. Meanwhile, Europe and the Asia Pacific are likely to grow at a significant rate in the forecast period owing to the ongoing healthcare reforms in the regions. The increasing focus to improve access to healthcare facilities in emerging countries of the Asia Pacific is expected to significantly contribute to the market growth in the forecast period.
Anaesthesia Drugs: Market Segmentation
Anaesthesia can be defined as the use of medicines to prevent pain during a medical procedure. Thus, the combination of medications that put a person in a sleep-like state before a surgery or some other medical procedure is known as anaesthetic drug. Anaesthetic drugs are used to ensure that a patient is in a completely unconscious state so that he/she does not feel any kind of pain.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on route of administration, the market is divided into:
- Inhalation
- Injection
- Others
On the basis of drug type, the industry is segmented into:
- General Drug
- Local Drug
While the general drug segment is further divided into propofol, sevoflurane, desflurane, dexmedetomidine, remifentanil, midazolam, and others, the local drug segment is further categorised into bupivacaine, ropivacaine, lidocaine, chloroprocaine, prilocaine, benzocaine, and others.
The significant applications of the product are:
- General Surgery
- Plastic Surgery
- Cosmetic Surgery
- Dental Surgery
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Prevalence of Gastrointestinal Diseases to Boost the Growth of the Anaesthesia Drugs Industry
The global anaesthesia drugs industry is driven by the rising prevalence of gastrointestinal diseases, such as gastroesophageal disease, liver cirrhosis, pancreatitis, and inflammatory bowel disease, among others. These diseases require intense surgery to attack the root of the disease, therefore, appropriate anaesthesia is needed for the safety of the patients. In addition, the easy availability of local drugs and the increasing hospitalisation rates are significantly contributing to the market growth. Over the forecast period, the market is expected to be aided by the rapid advancements in the healthcare industry.
Key Industry Players in the Global Anaesthesia Drugs Market
The report gives a detailed analysis of the following key players in the global anaesthesia drugs market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Pfizer Inc.
- Fresenius SE & Co. KGaA
- Baxter International, Inc.
- AbbVie Inc.
- B. Braun Melsungen AG
- Piramal Enterprises Limited
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Route of Administration, Drug Type, Application, Regions |
| Breakup by Route of Administration | Inhalation, Injection, Others |
| Breakup by Drug Type | General Drug, Local Drug |
| Breakup by Application | General Surgery, Plastic Surgery, Cosmetic Surgery, Dental Surgery, Others |
| Breakup by Regions | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles-Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Pfizer Inc., Fresenius SE & Co. KGaA, Baxter International, Inc., AbbVie Inc., B. Braun Melsungen AG, Piramal Enterprises Limited, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Anaesthesia Drugs Market Analysis
8.1 Key Industry Highlights
8.2 Global Anaesthesia Drugs Historical Market (2018-2022)
8.3 Global Anaesthesia Drugs Market Forecast (2023-2028)
8.4 Global Anaesthesia Drugs Market by Route of Administration
8.4.1 Inhalation
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Injection
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Others
8.5 Global Anaesthesia Drugs Market by Drug Type
8.5.1 General Drug
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.1.4 Breakup by Type
8.5.1.4.1 Propofol
8.5.1.4.2 Sevoflurane
8.5.1.4.3 Desflurane
8.5.1.4.4 Dexmedetomidine
8.5.1.4.5 Remifentanil
8.5.1.4.6 Midazolam
8.5.1.4.7 Others
8.5.2 Local Drug
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.2.4 Breakup by Type
8.5.2.4.1 Bupivacaine
8.5.2.4.2 Ropivacaine
8.5.2.4.3 Lidocaine
8.5.2.4.4 Chloroprocaine
8.5.2.4.5 Prilocaine
8.5.2.4.6 Benzocaine
8.5.2.4.7 Others
8.6 Global Anaesthesia Drugs Market by Application
8.6.1 General Surgery
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Plastic Surgery
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Cosmetic Surgery
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Dental Surgery
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2018-2022)
8.6.4.3 Forecast Trend (2023-2028)
8.6.5 Others
8.7 Global Anaesthesia Drugs Market by Region
8.7.1 North America
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2022)
8.7.1.3 Forecast Trend (2023-2028)
8.7.2 Europe
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2022)
8.7.2.3 Forecast Trend (2023-2028)
8.7.3 Asia Pacific
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2022)
8.7.3.3 Forecast Trend (2023-2028)
8.7.4 Latin America
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2018-2022)
8.7.4.3 Forecast Trend (2023-2028)
8.7.5 Middle East and Africa
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2018-2022)
8.7.5.3 Forecast Trend (2023-2028)
9 North America Anaesthesia Drugs Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Anaesthesia Drugs Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Anaesthesia Drugs Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Anaesthesia Drugs Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Anaesthesia Drugs Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Pfizer Inc.
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Fresenius SE & Co. KGaA
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Baxter International, Inc.
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 AbbVie Inc.
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 B. Braun Melsungen AG
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Piramal Enterprises Limited
16.2.6.1 Company Overview
16.2.6.2 Product Portfolio
16.2.6.3 Demographic Reach and Achievements
16.2.6.4 Certifications
16.2.7 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Anaesthesia Drugs Market: Key Industry Highlights, 2018 and 2028
2. Global Anaesthesia Drugs Historical Market: Breakup by Route of Administration (USD Billion), 2018-2022
3. Global Anaesthesia Drugs Market Forecast: Breakup by Route of Administration (USD Billion), 2023-2028
4. Global Anaesthesia Drugs Historical Market: Breakup by Drug Type (USD Billion), 2018-2022
5. Global Anaesthesia Drugs Market Forecast: Breakup by Drug Type (USD Billion), 2023-2028
6. Global Anaesthesia Drugs Historical Market: Breakup by Application (USD Billion), 2018-2022
7. Global Anaesthesia Drugs Market Forecast: Breakup by Application (USD Billion), 2023-2028
8. Global Anaesthesia Drugs Historical Market: Breakup by Region (USD Billion), 2018-2022
9. Global Anaesthesia Drugs Market Forecast: Breakup by Region (USD Billion), 2023-2028
10. North America Anaesthesia Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
11. North America Anaesthesia Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
12. Europe Anaesthesia Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
13. Europe Anaesthesia Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
14. Asia Pacific Anaesthesia Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
15. Asia Pacific Anaesthesia Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
16. Latin America Anaesthesia Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
17. Latin America Anaesthesia Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
18. Middle East and Africa Anaesthesia Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
19. Middle East and Africa Anaesthesia Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
20. Global Anaesthesia Drugs Market Structure
Key Questions Answered in the Report
In 2020, the global anaesthesia drugs market attained a volume of nearly USD 5.91 billion.
The market is estimated to grow at a CAGR of 3.4% in the forecast period of 2023-2028.
The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach USD 7.22 billion by 2026.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Inhalation, and injection, among others are the different routes of administration of the product.
General drug (propofol, sevoflurane, desflurane, dexmedetomidine, remifentanil, midazolam, and others) and local drug (bupivacaine, ropivacaine, lidocaine, chloroprocaine, prilocaine, benzocaine, and others) are the different drug types of the product.
General surgery, plastic surgery, cosmetic surgery, and dental surgery, among others are the significant applications of the product.
The major players in the industry are Pfizer Inc., Fresenius SE & Co. KGaA, Baxter International, Inc., AbbVie Inc., B. Braun Melsungen AG, and Piramal Enterprises Limited, among others.
Analyst Review
The global anaesthesia drugs market attained a value of almost USD 5.91 billion in 2020, driven by the growing prevalence of gastrointestinal diseases, growing use of local drugs, and improving healthcare industry. Aided by the rapid advancements in drug delivery methods and anaesthesiology techniques, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 3.4%. The market is projected to reach USD 7.22 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on route of administration, the market is divided into inhalation and injection, among others. On the basis of drug type, the market is divided into general drug and local drug. Among these, while the general drug segment is further divided into propofol, sevoflurane, desflurane, dexmedetomidine, remifentanil, midazolam, and others, the local drug segment is further categorised into bupivacaine, ropivacaine, lidocaine, chloroprocaine, prilocaine, benzocaine, and others. The significant applications of the product include general surgery, plastic surgery, cosmetic surgery, and dental surgery, among others. The major regional markets for anaesthesia drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Pfizer Inc., Fresenius SE & Co. KGaA, Baxter International, Inc., AbbVie Inc., B. Braun Melsungen AG, and Piramal Enterprises Limited, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER